← Evidence map

ArticleCancers2025

Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.

Peter Oppelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. | OpenQuestion